What's new

EMEA-003389-PIP01-23

EMEA-003389-PIP01-23

Mar 17, 2025 - 16:38
 0
EMEA-003389-PIP01-23
EMEA-003389-PIP01-23
Read More

Tags:

Previous Article

Curevo rounds up $110M to challenge GSK’s Shringrix, nabs Moncef Slaoui to lead ...

Next Article

The D Brief: Strikes in Yemen; Border destroyer; DOGE vs. nuclear-security agenc...

Related Posts

Human medicines European public assessment report (EPAR): Remsima, infliximab, Date of authorisation: 10/09/2013, Revision: 43, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 5, 2025  0

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – June 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 26 June 2025, 10:00 (CEST) to 26 June 2025, 12:00 (CEST)

Meeting of the Executive Steering Group on Shortages an...

Feb 9, 2025  0

List of medicines currently in PRIME scheme

Feb 9, 2025  0